China Universal Asset Management »

Caribou Biosciences shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $88k 17k 5.17
2023-12-31 $59k 10k 5.77
2023-09-30 $11k 2.3k 4.87
2023-06-30 $3.0k 805 3.73
2023-03-31 $4.0k 827 4.84
2022-12-31 $4.0k 620 6.45
2022-09-30 $6.0k 570 10.53

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Caribou Biosciences

Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Dimensional Fund Advisors
Bank of America Corporation
Candriam Luxembourg S.C.A.
Kynam Capital Management
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital
Jpmorgan Chase & Co

View all funds holding Caribou Biosciences